Two African nations became the first countries to approve the new R21/Matrix-M™ malaria vaccine, developed at Oxford University, includes Novavax's world-class adjuvant, and is manufactured by the Serum Institute of India (SII), Pvt. Ltd.
This year, Ghana and Nigeria preempted the World Health Organization (WHO) process and issued their approvals. And about ten other African countries may issue their approvals soon.
Read More
